Modulations in hepatic branch-point enzymes involved in isoprenoid biosynthesis upon dietary and drug treatments of rats.
Three branch-point enzymes of the mevalonate pathway, farnesyl pyrophosphate synthase, cis-prenyltransferase and squalene synthase were characterized in rat hepatic cytosol, microsomes and peroxisomes isolated from rats after treatment with peroxisome proliferators, inducers of the endoplasmic reticulum or modulators of lipid metabolism. Cholestyramine and phenobarbital induced primarily the cytosolic farnesyl pyrophosphate synthase, whereas clofibrate and phthalates elevated the corresponding peroxisomal activity. cis-Prenyltransferase activities in microsomes were induced 4-5-fold after clofibrate, phthalate and phenobarbital administration, but these same treatments affected the peroxisomal activity to only a limited extent. Squalene synthase activity in microsomes was completely abolished, but the peroxisomal activity was unaffected after administration of cholesterol. On the other hand, clofibrate and phthalate induced only the microsomal activities. Mevinolin treatment greatly increased peroxisomal and cytosolic farnesyl pyrophosphate synthase activities, but not the mitochondrial activity, and the cis-prenyltransferase activities were elevated in peroxisomes, but not in microsomes. These results demonstrate that the branch-point enzymes in cholesterol and dolichol biosynthesis at various cellular locations are regulated differentially and that the capacities of peroxisomes and the endoplasmic reticulum to participate in the synthesis of polyisoprenoid lipids is affected profoundly by treatment with different xenobiotics.
Andersson
M
M
Clinical Research Center, Huddinge Hospital, Sweden.
Ericsson
J
J
Appelkvist
E L
EL
Schedin
S
S
Chojnacki
T
T
Dallner
G
G
D000818:Animals; D002784:Cholesterol / Q000378:metabolism; D002791:Cholesterol, Dietary / Q000494:pharmacology; D002792:Cholestyramine Resin / Q000494:pharmacology; D003600:Cytosol / Q000201:enzymology; D004032:Diet; D004122:Dimethylallyltranstransferase / Q000378:metabolism; D004286:Dolichols / Q000378:metabolism; D013186:Farnesyl-Diphosphate Farnesyltransferase / Q000378:metabolism; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D008148:Lovastatin / Q000494:pharmacology; D008297:Male; D008830:Microbodies / Q000201:enzymology; D008862:Microsomes, Liver / Q000201:enzymology; D010634:Phenobarbital / Q000494:pharmacology; D011106:Polyisoprenyl Phosphates / Q000096:biosynthesis*; D051381:Rats; D017207:Rats, Sprague-Dawley
D002791:Cholesterol, Dietary; D004286:Dolichols; D011106:Polyisoprenyl Phosphates; D002792:Cholestyramine Resin; D002784:Cholesterol; D008148:Lovastatin; D004122:Dimethylallyltranstransferase; D013186:Farnesyl-Diphosphate Farnesyltransferase; D010634:Phenobarbital